Effect of Physical Exercise Program on Fetoplacental Growth

Sponsor
Universidad Politecnica de Madrid (Other)
Overall Status
Unknown status
CT.gov ID
NCT02420288
Collaborator
(none)
124
1
2
85
1.5

Study Details

Study Description

Brief Summary

The aim of this study is to examine the effect of a supervised physical exercise program during pregnancy on fetoplacental growth.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Exercise Group
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
124 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Effect of Physical Exercise Program on Fetoplacental Growth: a Randomized Controlled Trial
Study Start Date :
Nov 1, 2014
Actual Primary Completion Date :
Dec 1, 2016
Anticipated Study Completion Date :
Dec 1, 2021

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control Group

Pregnant women not participating in supervised physical exercise program. The subjects in this group will be monitored during pregnancy to know if they make any kind of exercise on your own, to know which are really sedentary pregnant women.

Experimental: Exercise Group

Pregnant women participating in supervised physical exercise program.

Behavioral: Exercise Group
Supervised physical conditioning program of three 55-60 minute sessions per week during whole pregnancy (before week 16 to 38). Each session consists of 25-30 minutes of cardiovascular exercise,10 minutes of specific exercises (strength and balance exercises), and 10 minutes of pelvic floor muscles training. Aerobic activity was prescribed at light to moderate intensity, aiming for 55-60% of heart rate reserve. All subjects wore a heart rate (HR) monitor (Polar FT7) during the training sessions to ensure that exercise intensity was light to moderate.
Other Names:
  • Supervised physical exercise program group
  • Outcome Measures

    Primary Outcome Measures

    1. Placental weight [At delivery]

    2. Fetal birth weight [At delivery]

    3. Change from baseline in maternal gestational weight [38-42 weeks of gestation]

      Maternal weight gain during pregnancy. Weight will be measured at the beginning and at the end of the pregnancy

    Secondary Outcome Measures

    1. Pregestational weight and Body Mass Index (BMI) [Before pregnancy]

    2. pH umbilical cord [At delivery]

    3. Fetal size outcomes [At delivery]

      Size and height, head circumference and body mass index of the baby

    4. Fetal glycemia level [At delivery]

    5. Apgar score [At delivery]

      Apgar score will be valued 1 and 5 minutes after delivery

    6. Maternal delivery outcomes (composite) [At delivery]

      Type of labor, stage and duration of labor

    7. Postpartum depression [0-12 postpartum months]

      The level of maternal depression after delivery will be measured with the Edinburgh Postnatal Depression Scale (EPDS)

    8. Changes from baseline in prenatal depression [Up to 36 weeks]

      The level of maternal depression during pregnancy will be measured at the beginning and at the end of the pregnancy, as well as at 8 weeks postpartum, with the Center for Epidemiologic Studies Depression Scale (CES-D)

    9. Changes from baseline in maternal quality of life [Up to 36 weeks]

      Maternal quality of life will be measured at the beginning and at the end of the pregnancy, as well as at 8 weeks postpartum, with the Short Form-36 Health Survey (SF-36)

    10. Changes from baseline in urinary incontinence [Up to 36 weeks]

      Urinary incontinence will be measured at the beginning and at the end of the pregnancy, as well as at 8 weeks postpartum, with the International Consultation on Incontinence Questionnaire Short-Form (ICIQ-SF)

    11. Gestational diabetes [24-28 weeks]

      Gestational diabetes will be measured with the O' Sullivan's test

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 45 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Being healthy and able to exercise following American College of Obstetricians and Gynecologists (ACOG) guidelines

    • Being able to communicate in spanish

    • Giving birth at Hospital Universitario de Torrejón, Hospital Universitario de Puerta de Hierro or Hospital Universitario Severo Ochoa (Madrid)

    Exclusion Criteria:
    • Multiparity

    • Obstetrician complications

    • Being interested in the study after 18 weeks

    • Not having availability to attend to the physical exercise program

    • Younger than 18 years old

    • Older than 45 years old

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Universidad Politécnica de Madrid Madrid Spain 28040

    Sponsors and Collaborators

    • Universidad Politecnica de Madrid

    Investigators

    • Study Director: Rubén Barakat Carballo, PhD, Universidad Politécnica de Madrid

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Marina Vargas Terrones, PhD student, Universidad Politecnica de Madrid
    ClinicalTrials.gov Identifier:
    NCT02420288
    Other Study ID Numbers:
    • INEF-001
    First Posted:
    Apr 17, 2015
    Last Update Posted:
    Jun 25, 2019
    Last Verified:
    Jun 1, 2019
    Keywords provided by Marina Vargas Terrones, PhD student, Universidad Politecnica de Madrid

    Study Results

    No Results Posted as of Jun 25, 2019